Skip to main content

Table 3 Imaging and medications of patients regarding access to care, by race

From: Healthcare disparities in cardio oncology: patients receive same level of surveillance regardless of race at a safety net hospital

 

Black

(N = 68)

White

(N = 41)

Hispanic (N = 33)

Other

(N = 7)

P-value

Number of patients with additional cardiac imaging

 MUGA scan

8

3

5

0

p = 0.55

 Cardiac CT/MRI

2

3

1

0

p = 0.63

 Stress test

13

9

8

1

p = 0.89

 RHC

3

3

0

0

p = 0.42

 LHC

4

3

1

0

p = 0.78

Medication post-chemo

 Beta blocker

38

20

14

7

p = 0.12

 ACEI/ARB

43

18

12

3

p = 0.047

 Diuretic

20

13

6

1

p = 0.54

 CCB

20

6

4

2

p = 0.13

 Hydralazine

5

2

0

0

p = 0.38

 Nitrate

2

3

0

0

p = 0.33

 MRA

2

4

1

1

p = 0.28

 Antiarrhythmic

2

2

0

0

p = 0.60

 Aspirin

19

15

7

3

p = 0.43

 Statin

24

16

11

3

p = 0.94